Publication: Antimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers
dc.contributor.coauthor | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Kılıç, Yağmur | |
dc.contributor.kuauthor | Şahin, Gizem Nur | |
dc.contributor.kuauthor | Karanfil, Işıl | |
dc.contributor.kuauthor | Eryılmaz, Baldan | |
dc.contributor.kuauthor | Yılmaz, Pelinsu | |
dc.contributor.kuauthor | Özkanbaş, Necmettin Can | |
dc.contributor.kuauthor | Öktem, Özgür | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.kuprofile | PhD Student | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.kuprofile | Undergraduate Student | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | Graduate School of Health Sciences | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 102627 | |
dc.date.accessioned | 2024-11-09T23:27:58Z | |
dc.date.issued | 2014 | |
dc.description.abstract | N/A | |
dc.description.indexedby | WoS | |
dc.description.openaccess | NO | |
dc.description.volume | 29 | |
dc.identifier.doi | N/A | |
dc.identifier.eissn | 1460-2350 | |
dc.identifier.issn | 0268-1161 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/11806 | |
dc.identifier.wos | 359745300393 | |
dc.keywords | N/A | |
dc.language | English | |
dc.publisher | Oxford Univ Press | |
dc.source | Human Reproduction | |
dc.subject | Obstetrics | |
dc.subject | Gynecology | |
dc.subject | Reproductive biology | |
dc.title | Antimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | 0000-0003-1966-3886 | |
local.contributor.kuauthor | Kılıç, Yağmur | |
local.contributor.kuauthor | Şahin, Gizem Nur | |
local.contributor.kuauthor | Karanfil, Işıl | |
local.contributor.kuauthor | Eryılmaz, Baldan | |
local.contributor.kuauthor | Yılmaz, Pelinsu | |
local.contributor.kuauthor | Özkanbaş, Necmettin Can | |
local.contributor.kuauthor | Öktem, Özgür |